Cargando…
The quest for the holy grail: new antitubercular chemical entities, targets and strategies
Tuberculosis (TB) remains the leading cause of death from an infectious disease worldwide. TB therapy is complicated by the protracted treatment regimens, development of resistance coupled with toxicity and insufficient sterilizing capacity of current drugs. Although considerable progress has been m...
Autores principales: | Huszár, Stanislav, Chibale, Kelly, Singh, Vinayak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd. ;, Distributed by Virgin Mailing and Distribution
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215093/ https://www.ncbi.nlm.nih.gov/pubmed/32062007 http://dx.doi.org/10.1016/j.drudis.2020.02.003 |
Ejemplares similares
-
Endometriosis Classification-The Quest for the Holy Grail?
por: Khazali, Shaheen
Publicado: (2016) -
Presepsin: Hope in the Quest for the Holy Grail
por: Samprathi, Abhishek, et al.
Publicado: (2022) -
Biased agonism: the quest for the analgesic holy grail
por: Stanczyk, M. Alexander, et al.
Publicado: (2018) -
Management of T-Cell Lymphoma: In Quest of the Holy Grail
por: Péricart, Sarah, et al.
Publicado: (2021) -
Cardioprotection From Cardiotoxicity: The Quest for the Holy Grail Goes On
por: Oliveira, Guilherme H.
Publicado: (2019)